Roswell Park Comprehensive Cancer Center is a cancer research and treatment center located in Buffalo, New York. Founded by Roswell Park in 1898, the center was the first in the United States to specifically focus on cancer research.

There are 133 (licensed) beds in Roswell Park Cancer Institute.

During the past decade, Roswell Park Cancer Institute conducted 703 clinical trials. In the 10-year time frame, 703 clinical trials started and 467 clinical trials were completed, i.e. on average, 66.4% percent of trials that started reached the finish line to date. In the past 5 years, 293 clinical trials started and 225 clinical trials were completed. i.e. 76.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Roswell Park Cancer Institute" #1 sponsor was "Roswell Park Cancer Institute" with 324 trials, followed by "National Cancer Institute (NCI)" with 216 trials sponsored, "Children's Oncology Group" with 140 trials sponsored, "Alliance for Clinical Trials in Oncology" with 122 trials sponsored and "Radiation Therapy Oncology Group" with 122 trials sponsored. Other sponsors include 727 different institutions and companies that sponsored additional 300 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Roswell Park Cancer Institute" #1 collaborator was "National Cancer Institute (NCI)" with 603 trials as a collaborator, "NRG Oncology" with 46 trials as a collaborator, "Cancer and Leukemia Group B" with 27 trials as a collaborator, "National Marrow Donor Program" with 23 trials as a collaborator and "SWOG Cancer Research Network" with 21 trials as a collaborator. Other collaborators include 544 different institutions and companies that were collaborators in the rest 235 trials.

According to Clinical.Site data, the most researched conditions in "Roswell Park Cancer Institute" are "Leukemia" (76 trials), "Lymphoma" (65 trials), "Breast Cancer" (62 trials), "Acute Myeloid Leukemia" (57 trials) and "Prostate Cancer" (54 trials). Many other conditions were trialed in "Roswell Park Cancer Institute" in a lesser frequency.

Most popular intervention types in "Roswell Park Cancer Institute" are "Drug" (1221 trials), "Other" (500 trials), "Biological" (425 trials), "Procedure" (317 trials) and "Radiation" (209 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (221 trials), "Quality-of-Life Assessment" (117 trials), "Questionnaire Administration" (103 trials), "radiation therapy" (80 trials) and "Cyclophosphamide" (77 trials). Other intervention names were less common.

The vast majority of trials in "Roswell Park Cancer Institute" are 1353 trials for "All" genders, 150 trials for "Female" genders and 87 trials for "Male" genders.

Currently, there are NaN active trials in "Roswell Park Cancer Institute". 5 are not yet recruiting, 263 are recruiting, 300 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 796 completed trials in Roswell Park Cancer Institute, 9 suspended trials, and 159 terminated clinical trials to date.

Out of the total trials that were conducted in Roswell Park Cancer Institute, 389 "Phase 1" clinical trials were conducted, 731 "Phase 2" clinical trials and 427 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 111 trials that are defined as “Not Applicable".

Roswell Park Cancer Institute has several departments that took part in Clinical trials: "Charles B. Eberhart Cancer Center at DeKalb Medical Center" - 52 trials, "Roswell Park Cancer Institute (Data Collection Only)" - 2 trials, "Roswell Park Cancer Institute; Grace Cancer Drug Center" - 2 trials